Delivery Order SPE2DB25D3018-SPE2DB25FUXSD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $20,575.76 to AmerisourceBergen Drug Corp for the supply of Diovan HCT 160-12.5 mg tablets (90-count) under a firm fixed price arrangement. The award was made on August 1, 2025, with an ultimate completion date of August 4, 2025, and is classified as a non-set-aside competitive procurement. Performance will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Diovan HCT 160-12.5 mg tablets (90-count) with a ceiling value of $17,047.43. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is due for completion by August 13, 2025. The award was executed from AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order valued at $97,006.28 to AmerisourceBergen Drug Corp for the supply of Diovan HCT 160-25 mg tablets (90-count) under a firm fixed price contract. The award, issued on July 23, 2025, with completion by July 24, 2025, represents a competitive procurement with no set-aside designation. Performance will be executed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $9,967.16 to AmerisourceBergen Drug Corp for the supply of Diovan HCT 160-12.5 mg tablets (90-count units) on August 6, 2025, with completion scheduled for August 7, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child order issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Diovan HCT 320-12.5 mg tablets (90-count supply) on September 29, 2025, with a ceiling value of $1,927.00 and completion deadline of September 30, 2025. This firm fixed-price delivery order is non-competitive and represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle active...
- The Defense Logistics Agency awarded a delivery order valued at $5,570.45 to AmerisourceBergen Drug Corp for the supply of Diovan HCT 320-25 mg tablets (90-count units) under a firm fixed price arrangement. The contract was awarded on July 29, 2025, with an ultimate completion date of July 30, 2025, and does not utilize a set-aside designation. Performance will take place at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Diovan HCT 160-12.5 mg tablets (90 count) with a contract value of $2,386.06. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 20, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting AmerisourceBergen's capability...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Diovan HCT 160-25 mg tablets (90 count) with a ceiling value of $1,038.57. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The order is scheduled for completion by August 11, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. This delivery order represents a task...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Diovan HCT 320-12.5 mg tablets (90-count units) with a ceiling value of $2,560.36 and an ultimate completion date of September 8, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating the contract was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $6,802.24 to AmerisourceBergen Drug Corp for the supply of Diovan HCT 160-25 mg tablets in quantities of 90 units. This competitively awarded, firm fixed-price delivery order was issued on July 14, 2025, with an ultimate completion date of July 15, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- SPE2DB25D3018Indefinite Delivery Contract
- SPE2DB25D3018-SPE2DB25FUXSDDelivery Order
The Defense Logistics Agency awarded a $9,573.76 delivery order to AmerisourceBergen Drug Corp on June 9, 2025, for the supply of Diovan HCT 160-25 mg tablets (90-count units). This firm fixed-price delivery order, with an ultimate completion date of June 10, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The contract was competitively awarded without set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Diovan HCT is a combination antihypertensive medication used to treat high blood pressure, reflecting the ongoing pharmaceutical supply requirements of military and veteran healthcare systems. This delivery order falls under AmerisourceBergen's comprehensive Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal vendor for medical procurement across multiple therapeutic domains. The company's DLA prime vendor contract enables the supply of brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs globally, including services to the Defense Health Agency and U.S. Coast Guard. This specific delivery order exemplifies the company's role in fulfilling routine pharmaceutical procurement needs within the broader defense medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.6k | 6/9/25 |